Nanoplastics (<1μm plastic particles) in food: ingestion safety
Elevated risk(People-specific data is limited; this page draws from human adult context.) Sub-1μm particles from degradation of larger plastics. Can cross biological barriers (gut epithelium, blood-brain barrier, placenta) that microplastics cannot. Columbia University study (2024) found 240,000 nanoplastic particles per liter of bottled water. Associated with oxidative stress, inflammation, and potential cellular uptake. Science is early but concern level is high.
What is nanoplastics (<1μm plastic particles)?
Also known as: Nanoplastics, Nano-sized plastic particles, Sub-micron plastics, Plastic nanoparticles.
- —
- —
Risk for people
Elevated riskSub-1μm particles from degradation of larger plastics. Can cross biological barriers (gut epithelium, blood-brain barrier, placenta) that microplastics cannot. Columbia University study (2024) found 240,000 nanoplastic particles per liter of bottled water. Associated with oxidative stress, inflammation, and potential cellular uptake. Science is early but concern level is high.
Regulatory consensus
2 regulatory and scientific bodies have classified Nanoplastics (<1μm plastic particles). The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EU | 2024 | Under ECHA assessment — no specific regulation yet; covered broadly by (EU) 2023/2055 for intentionally added particles | |
| WHO | 2022 | Research priority — insufficient evidence for health-based guidelines (2022 report) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where you encounter nanoplastics (<1μm plastic particles)
- Drinking Water
- Food
- Air
- Human Tissue
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Nanoplastics (<1μm plastic particles):
-
Biodegradable polymer nanoparticles (PLA, PLGA)
Trade-offs: Shorter circulation time. Acidic degradation products. Higher cost.Relative cost: 10-50× conventional nanoparticles
-
Protein-based nanocarriers (albumin, gelatin)
Trade-offs: Batch-to-batch variability. Potential immunogenicity. Limited shelf stability.Relative cost: Variable
Frequently asked questions
No FAQ entries generated.
See Nanoplastics (<1μm plastic particles) in the food app
Look up products containing nanoplastics (<1μm plastic particles), compare to alternatives, and explore the full data record.
Open in food View raw API dataSources (1)
- —
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →